Best Mochi Health Alternatives for GLP-1 Treatment in 2026 — 2026

Last reviewed: September 11, 2026 Last updated: September 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Mochi Health's advertised $99/month compounded semaglutide and $129/month compounded tirzepatide (starting doses, medication plus $39/month membership; captured September 4, 2026; joinmochi.com) represent the lowest entry prices in the verified comparison set. However, Mochi uses per-dose pricing—your medication cost increases as your dose escalates—so the starting figure understates the long-term expense for most patients who titrate upward. If you want predictable monthly costs at every dose, seven alternatives offer flat-rate models: PlexusDx ($189 month-to-month semaglutide injection, $149 on a six-month plan; $289/$249 tirzepatide; same price at every dose, no membership), Eden ($198 semaglutide, $298 tirzepatide all-in), Embody ($299/$349), Found (from $289/$359 cash month-to-month), Henry Meds ($297 semaglutide), Peak Wellness ($249/$349), and TrimRx ($299/$399 checkout-verified ongoing). Among flat-rate providers, PlexusDx's six-month semaglutide rate ($149/month, $1,788/year) and tirzepatide rate ($249/month, $2,988/year) sit below most alternatives on an annual basis while holding constant regardless of dose. Mochi holds a 4.5-star Trustpilot rating with approximately 18,000 reviews; PlexusDx holds 4.3 stars with 79 percent five-star and 83 percent four-star or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com). The best choice depends on whether you prioritize the lowest possible starting price or a locked monthly rate that won't change when your clinician increases your dose.

At-a-glance comparison: Mochi Health and seven alternatives

All figures captured July 17–23, 2026 (PlexusDx, Eden, Embody, Found, Henry Meds, Peak Wellness, TrimRx) and September 4, 2026 (Mochi Health). Mochi's per-dose model means medication cost increases at higher doses; the $99 semaglutide and $129 tirzepatide figures apply to first-month starting doses only (medication plus advertised first-month membership). Confirm ongoing membership fee and dose-specific pricing at checkout.

Normalized 12-month pricing: per-dose vs. flat-rate models

Mochi Health's per-dose pricing yields a $1,188 annual cost for semaglutide at the starting dose ($99/month × 12; our calculation) and $1,548 for tirzepatide at the starting dose ($129/month × 12; our calculation). These figures assume the starting dose continues for twelve months, which is not typical in clinical practice—most patients titrate upward over the first three to five months, and Mochi's medication component rises with each dose increase. The company's September 4, 2026 blog post (joinmochi.com/blog/per-dose-pricing-mochi-health) states that "medication cost increases at higher doses" but does not publish a dose-by-dose schedule, so projecting the year-one effective cost requires assumptions about titration speed and maintenance dose.

In contrast, flat-rate providers lock the monthly price regardless of dose. PlexusDx's semaglutide injection costs $2,268 per year on the month-to-month plan ($189 × 12; our calculation) or $1,788 per year on the six-month plan ($149 × 12; our calculation), and tirzepatide costs $3,468 per year month-to-month ($289 × 12; our calculation) or $2,988 per year on the six-month plan ($249 × 12; our calculation). Eden's all-in model (medication $99 + membership $99) totals $2,376 per year for semaglutide ($198 × 12; our calculation) and $3,576 for tirzepatide ($298 × 12; our calculation). Embody charges $3,588 annually for semaglutide ($299 × 12; our calculation) and $4,188 for tirzepatide ($349 × 12; our calculation), with the same price at every dose and no membership. Found's cash month-to-month track costs $3,468 per year for semaglutide ($289 × 12; our calculation) and $4,308 for tirzepatide ($359 × 12; our calculation); the 12-month prepaid option drops the semaglutide-equivalent rate to $169/month ($2,028 per year paid upfront; our calculation) but requires full payment at enrollment. Henry Meds charges $297/month for semaglutide ($3,564 annually; our calculation) with no separate membership, though tirzepatide is offered only as an oral dissolving tablet (no injection rate listed). Peak Wellness charges $249/month semaglutide ($2,988 annually; our calculation) and $349/month tirzepatide ($4,188 annually; our calculation) on the month-to-month plan, with lower per-month rates on six-month prepaid plans. TrimRx's checkout-verified ongoing rates are $299/month semaglutide ($3,588 annually; our calculation) and $399/month tirzepatide ($4,788 annually; our calculation), despite advertised figures of $199 and $349; the provider offers lower per-month rates on three-, six-, and twelve-month plans charged upfront.

If you remain at Mochi's starting dose for a full year, the $1,188 semaglutide cost undercuts every flat-rate alternative. If you titrate to a maintenance dose within three months and that dose costs, for example, $120/month in medication (a hypothetical figure—Mochi has not published a dose schedule), your effective annual cost becomes approximately $1,908 (3 × $99 first-month starting dose + 9 × $159 refill-rate month; our calculation), which falls between PlexusDx's six-month rate ($1,788) and Eden's all-in rate ($2,376). The lack of a published dose-pricing table makes it difficult to model the true 12-month cost without knowing your target maintenance dose in advance.

Mochi Health's per-dose model: what the evidence shows

Mochi Health announced its per-dose pricing model on September 4, 2026 (joinmochi.com/blog/per-dose-pricing-mochi-health). The blog post states that the company moved from flat monthly pricing to a structure in which "medication cost increases at higher doses" and cites transparency and cost control as the rationale. The starting-dose rates—$60 medication for semaglutide, $90 for tirzepatide—are paired with a $39/month membership that the source describes as "$39 first month membership." The packet does not document a second-month or ongoing membership rate, and the source includes the caveat "Confirm ongoing membership after promo," so it is unclear whether the membership fee remains $39 beyond the first month or increases. We recommend confirming the ongoing membership cost at signup. The complete first-month charge applies to the starting dose ($60 medication + $39 first-month membership, total $99 for semaglutide; $90 medication + $39 first-month membership, total $129 for tirzepatide). The company has not published a dose escalation price schedule, so refill-month costs at higher doses are not documented.

The per-dose model creates a different value proposition than flat-rate programs. Patients who respond at low doses and do not require escalation will pay less over time; patients who titrate to higher maintenance doses will see their monthly bill rise. Because GLP-1 receptor agonists are typically titrated upward every four weeks until the patient reaches an effective dose or experiences limiting side effects, most users will not remain at the starting dose indefinitely. The absence of a published dose-price schedule makes it difficult to budget the second half of year one or compare the effective annual cost to flat-rate alternatives without knowing your likely maintenance dose in advance.

Review record and service quality

Mochi Health holds a 4.5-star rating on Trustpilot with approximately 18,000 reviews (captured September 4, 2026; trustpilot.com). One captured review from the research packet reports that a provider appeared late to a virtual visit and did not actively engage during the consultation (individual allegation, not verified as representative); the research team notes that broader negative-theme coding is still in progress, so the full distribution of service complaints is not yet available. The large review volume and high average rating suggest that many users report satisfactory experiences, though the per-dose pricing model is recent (announced September 2026) and it is not clear how many of the 18,000 reviews reflect experience under the new pricing structure versus the older flat-rate model.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79 percent of reviews at five stars and 83 percent at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com). Eden, Embody, Found, Henry Meds, Peak Wellness, and TrimRx each have public review profiles, but the research packet does not include verified rating or theme data for those providers; readers should consult Trustpilot, Google Reviews, or the Better Business Bureau directly for current feedback.

Medication choice and route options

Mochi Health offers compounded semaglutide and tirzepatide injections and also lists branded GLP-1 options on its website (captured September 4, 2026; joinmochi.com/medications/compounded-tirzepatide). The research packet does not document Mochi's branded pricing or confirm whether the per-dose model applies to branded medications.

PlexusDx offers compounded semaglutide injection ($189/$169/$149 month-to-month / three-month / six-month), compounded tirzepatide injection ($289/$269/$249), compounded semaglutide oral capsules ($289/$269/$249), compounded tirzepatide oral capsules ($349/$299/$279), and a microdose GLP-1 protocol ($129/month month-to-month). The microdose protocol is designed for patients seeking a maintenance dose after reaching goal weight or for those who prefer a lower-intensity intervention. All PlexusDx compounded protocols carry the same per-month price at every dose, include the prescriber visit, medication, and shipping, and carry no membership fee.

Eden offers compounded injections (semaglutide $99 medication + $99 membership; tirzepatide $99 medication + $99 membership, though the all-in figures are $198 and $298). Embody offers compounded injections at $299 semaglutide and $349 tirzepatide with no membership. Found offers cash-pay compounded injections starting at $289 semaglutide and $359 tirzepatide month-to-month, plus a 12-month prepaid option. Henry Meds offers semaglutide injection at $297/month; tirzepatide is listed as an oral dissolving tablet only (no injection rate documented). Peak Wellness and TrimRx each offer compounded semaglutide and tirzepatide injections at the rates shown in the table above.

Membership fees and billing transparency

Mochi Health charges a $39/month membership (source states "first month," ongoing rate not documented; confirm at signup). Eden charges a required $99/month membership in addition to the $99 medication fee, bringing the true all-in cost to $198 semaglutide and $298 tirzepatide. PlexusDx, Embody, Henry Meds, Peak Wellness, and TrimRx charge no separate membership; the published monthly rate includes prescriber access, medication, and shipping. Found operates separate insurance and cash-pay tracks; the widely advertised "$99" figure applies to the insurance track and is not comparable to cash-pay or compounded rates.

When comparing advertised prices, separate the medication cost, membership or subscription fee, prescriber visit fee (if billed separately), lab fees, and shipping. Mochi's $99 first-month charge breaks into $60 medication + $39 advertised first-month membership; Eden's advertised "$99" is medication only, and the required membership brings the total to $198. TrimRx advertises $199 semaglutide but the checkout-verified ongoing rate is $299, a $100 difference. Always confirm the final monthly recurring charge—including all fees—at checkout before committing.

Choose Mochi Health if…

• You want the lowest possible entry price for compounded semaglutide ($99/month first-month starting dose) or tirzepatide ($129/month first-month starting dose) and are comfortable with the possibility that your medication cost will increase as your dose escalates.
• You expect to respond at a low dose and do not anticipate requiring the upper end of the dose range, making per-dose pricing an advantage rather than a liability.
• You value a large review base (approximately 18,000 Trustpilot reviews, 4.5-star average) and are willing to confirm the ongoing membership fee and dose-specific pricing at signup.

Choose a flat-rate alternative if…

• You want cost predictability and prefer a monthly rate that does not change when your clinician increases your dose.
• You are likely to titrate to a mid- or high-maintenance dose and want to avoid uncertainty about your second-half-of-year-one costs.
• You prefer a single all-inclusive monthly charge with no separate medication and membership line items.

Where PlexusDx fits

PlexusDx charges $189/month for compounded semaglutide injection on the month-to-month plan, $149/month on the six-month plan, and $289/$249 for compounded tirzepatide injection (month-to-month / six-month). The rate is the same at every dose—0.25 mg/week, 1 mg/week, and 2.4 mg/week semaglutide all cost $189 (or $149 on the six-month plan); 2.5 mg/week, 7.5 mg/week, and 15 mg/week tirzepatide all cost $289 (or $249 on the six-month plan). There is no membership fee, no prescriber visit charge, no lab fee, and no shipping fee; the published monthly rate is the final recurring charge. On an annual basis, PlexusDx's six-month semaglutide plan costs $1,788 (our calculation), which sits above Mochi's first-month starting-dose figure ($1,188) but below Eden ($2,376), Found month-to-month ($3,468), Henry Meds ($3,564), Peak Wellness ($2,988), Embody ($3,588), and TrimRx ($3,588). PlexusDx's six-month tirzepatide plan costs $2,988 per year (our calculation), lower than Eden ($3,576), Embody ($4,188), Found ($4,308), Peak Wellness ($4,188), and TrimRx ($4,788), though higher than Mochi's first-month starting-dose tirzepatide rate ($1,548 assuming the starting dose continues for twelve months).

PlexusDx also offers compounded semaglutide oral capsules ($289/$269/$249 month-to-month / three-month / six-month), compounded tirzepatide oral capsules ($349/$299/$279), and a microdose GLP-1 injection protocol ($129/month month-to-month). The microdose protocol is designed for patients who have reached goal weight and want a maintenance dose, or for those seeking a lower-intensity option. The oral capsules provide an alternative route for patients who prefer not to inject or who experience injection-site reactions. All routes and doses carry the same per-month price, and a licensed clinician determines whether a given medication and route are appropriate based on your medical history, current medications, and weight-management goals.

Compounded oral GLP-1: capsule alternatives to injection

PlexusDx offers compounded semaglutide oral capsules at $289/month month-to-month, $269/month on the three-month plan, and $249/month on the six-month plan, and compounded tirzepatide oral capsules at $349/$299/$279. Oral GLP-1 capsules are absorbed through the gastrointestinal tract and may be appropriate for patients who prefer not to inject, who travel frequently and want to avoid carrying syringes and refrigeration, or who experience persistent injection-site reactions. Bioavailability and dosing differ from subcutaneous injection, and a licensed clinician determines whether oral administration is suitable based on your medical history and treatment goals. The research packet does not document whether Mochi Health, Eden, Embody, Found, Henry Meds, Peak Wellness, or TrimRx offer compounded oral semaglutide or tirzepatide capsules; readers interested in non-injection routes should confirm availability directly with each provider.

Microdose GLP-1 for maintenance

PlexusDx's microdose GLP-1 protocol costs $129/month (month-to-month only) and is designed for patients who have reached goal weight and want a maintenance dose to support long-term weight stability, or for those seeking a lower-intensity intervention. The protocol uses a compounded GLP-1 receptor agonist at a sub-therapeutic or low-therapeutic dose. A licensed clinician reviews your intake, current weight, weight-loss history, and maintenance goals to determine whether the microdose protocol is appropriate. The microdose option is not suitable for patients beginning GLP-1 therapy or actively pursuing weight loss; it is a maintenance tool for patients who have already achieved their target weight or who prefer a minimal effective dose. At $129/month, the microdose protocol costs $1,548 per year (our calculation), the same annual cost as Mochi's first-month starting-dose tirzepatide and lower than any other verified alternative in the comparison set except Mochi's first-month starting-dose semaglutide ($1,188 annually at the starting dose). The research packet does not document microdose or maintenance-dose options from Mochi Health, Eden, Embody, Found, Henry Meds, Peak Wellness, or TrimRx.

What the pricing model reveals about long-term cost

Per-dose pricing rewards patients who respond at low doses and penalizes those who require higher doses to achieve efficacy. Flat-rate pricing spreads the cost evenly across all patients regardless of dose, which means low-dose responders subsidize high-dose responders within the same pricing tier. Neither model is inherently superior—your preference depends on your tolerance for cost uncertainty and your confidence in predicting your maintenance dose before starting therapy.

If you have previously used a GLP-1 medication and know your effective dose, you can ask Mochi Health for the exact monthly cost at that dose and compare it to the flat-rate alternatives. If you are new to GLP-1 therapy, you will not know your maintenance dose until you complete titration, which typically takes three to five months. In that scenario, a flat-rate model eliminates the risk that your monthly cost will double or triple as you titrate upward, though you may pay more than necessary if you respond at a low dose.

Mochi's first-month starting-dose semaglutide cost ($99/month, $1,188 annually) is $600 lower than PlexusDx's six-month semaglutide rate ($1,788 annually) over twelve months, assuming you remain at the starting dose for the full year. If your medication cost increases to $90/month at a mid-range dose (a hypothetical figure—Mochi has not published a dose schedule), your effective annual cost becomes approximately $1,836 (3 × $99 first-month starting dose + 9 × $129 refill-rate mid-range month; our calculation), which exceeds PlexusDx's six-month rate by $48. If your medication cost increases to $120/month at a high dose, your effective annual cost becomes approximately $2,205 (3 × $99 first-month starting dose + 9 × $159 refill-rate high-dose month; our calculation), which exceeds PlexusDx's six-month rate by $417. The crossover point depends on the dose-price schedule, which Mochi has not published, so we cannot calculate the exact maintenance dose at which the flat-rate alternatives become cheaper than Mochi's per-dose model.

Prepaid multi-month plans and upfront payment

PlexusDx, Found, Peak Wellness, and TrimRx each offer lower per-month rates when you prepay for three, six, or twelve months. PlexusDx's semaglutide injection drops from $189/month month-to-month to $149/month on the six-month plan (billed $894 every six months), a $40/month reduction. Tirzepatide drops from $289/month to $249/month on the six-month plan (billed $1,494 every six months). Found's 12-month prepaid semaglutide option costs $169/month equivalent (paid upfront, $2,028 total; our calculation), compared to $289/month on the month-to-month cash track. Peak Wellness advertises lower per-month rates on six-month prepaid plans but the packet does not document the exact figures. TrimRx offers lower per-month rates on three-, six-, and twelve-month plans charged upfront, though the checkout-verified month-to-month rates ($299 semaglutide, $399 tirzepatide) are the only figures verified at cart-level.

Prepaid plans reduce the effective monthly cost but require full payment at enrollment, which creates cash-flow risk if you discontinue treatment early due to side effects, lack of efficacy, insurance coverage changes, or other reasons. Month-to-month plans carry no upfront commitment and allow you to pause or cancel without forfeiting prepaid months. If you are new to GLP-1 therapy, a month-to-month plan during titration allows you to assess tolerability and response before committing to a longer billing cycle. If you have used a GLP-1 medication previously and are confident you will continue for six or twelve months, a prepaid plan delivers the lowest effective monthly rate among the flat-rate alternatives.

Methodology and freshness

We captured Mochi Health's per-dose pricing and membership fee from the company's September 4, 2026 blog post (joinmochi.com/blog/per-dose-pricing-mochi-health) and medication pages (joinmochi.com/medications/compounded-tirzepatide), accessed September 4, 2026. The source states "$39 first month membership" but does not document a second-month or ongoing membership rate; we advise readers to confirm the ongoing membership cost at signup. We captured PlexusDx pricing from live product pages July 17–23, 2026 and verified that the rates remain current as of September 11, 2026. We captured Eden, Embody, Found, Henry Meds, Peak Wellness, and TrimRx pricing at checkout or from public pricing pages July 17–23, 2026. TrimRx's advertised rates ($199 semaglutide, $349 tirzepatide) differ from the checkout-verified ongoing rates ($299, $399); we report both and label the source for each. Found's widely advertised "$99" figure applies to the insurance track, not the cash-pay or compounded track; we report the cash-pay month-to-month rates ($289 semaglutide, $359 tirzepatide) and the 12-month prepaid equivalent ($169/month semaglutide, paid upfront). All 12-month cost figures are our calculations (monthly rate × 12). We captured Mochi Health's Trustpilot rating (4.5 stars, approximately 18,000 reviews) and one negative-theme review on September 4, 2026; we captured PlexusDx's Trustpilot rating (4.3 stars, 79 percent five-star, 83 percent four-star or higher) on September 9, 2026 (trustpilot.com/review/plexusdx.com). Pricing, membership policies, dose schedules, and medication availability change; confirm all figures and policies at checkout before committing.

Frequently Asked Questions

Does Mochi Health's $99/month semaglutide price stay the same when my dose increases?

No. Mochi Health uses per-dose pricing, so the medication component of your monthly bill increases as your clinician raises your dose. The $99 figure applies to the first-month starting dose ($60 medication + $39 advertised first-month membership). The company has not published a dose-by-dose price schedule, so you cannot predict your cost at higher doses without contacting Mochi directly. Flat-rate alternatives like PlexusDx ($189 month-to-month, $149 six-month) charge the same price at every dose.

Which GLP-1 provider has the lowest annual cost for semaglutide?

Mochi Health's first-month starting-dose semaglutide costs $1,188 per year ($99/month × 12; our calculation), the lowest figure in the verified comparison set if you remain at the starting dose for twelve months. PlexusDx's six-month semaglutide plan costs $1,788 per year ($149/month × 12; our calculation) and holds that rate at every dose. If your Mochi medication cost increases above $60/month as you titrate, the effective annual cost will rise and may exceed PlexusDx's six-month rate depending on your maintenance dose.

Do I need to pay a membership fee for PlexusDx GLP-1 programs?

No. PlexusDx charges no membership fee. The published monthly rate ($189/$169/$149 semaglutide month-to-month / three-month / six-month; $289/$269/$249 tirzepatide) includes the prescriber visit, medication, and shipping. Mochi Health charges a $39/month membership (source states "first month," ongoing rate not documented), and Eden charges a required $99/month membership in addition to the $99 medication fee.

Can I switch from Mochi Health to PlexusDx and keep the same dose?

A licensed PlexusDx clinician reviews your intake, medical history, current medications, and prior GLP-1 experience to determine the appropriate starting dose. If you are currently using a GLP-1 medication through another provider, note your current dose, medication (semaglutide or tirzepatide), route (injection or oral), and response in your intake. The clinician may continue your current dose, adjust it, or recommend a different medication or route based on your individual clinical picture. PlexusDx cannot guarantee dose continuation without a provider review.

What is PlexusDx's microdose GLP-1 protocol and who is it for?

PlexusDx's microdose GLP-1 protocol costs $129/month (month-to-month only) and uses a compounded GLP-1 receptor agonist at a sub-therapeutic or low-therapeutic dose. It is designed for patients who have reached goal weight and want a maintenance dose to support long-term weight stability, or for those seeking a lower-intensity intervention. A licensed clinician determines whether the microdose protocol is appropriate based on your weight history, current weight, and maintenance goals. It is not suitable for patients beginning GLP-1 therapy or actively pursuing weight loss.

Sources

• Mochi Health per-dose pricing announcement, joinmochi.com/blog/per-dose-pricing-mochi-health, accessed September 4, 2026
• Mochi Health compounded tirzepatide medication page, joinmochi.com/medications/compounded-tirzepatide, accessed September 4, 2026
• PlexusDx semaglutide injection product page, plexusdx.com/products/semaglutide-injection, accessed July 17–23, 2026 and verified September 11, 2026
• PlexusDx tirzepatide injection product page, plexusdx.com/products/tirzepatide-injection, accessed July 17–23, 2026 and verified September 11, 2026
• PlexusDx microdose GLP-1 product page, plexusdx.com/products/microdose-glp1-protocol, accessed July 17–23, 2026 and verified September 11, 2026
• Eden, Embody, Found, Henry Meds, Peak Wellness, TrimRx pricing pages and checkout flows, accessed July 17–23, 2026
• Mochi Health Trustpilot profile, trustpilot.com (rating 4.5 stars, approximately 18,000 reviews), accessed September 4, 2026
• PlexusDx Trustpilot profile, trustpilot.com/review/plexusdx.com (rating 4.3 stars, 79% five-star, 83% four-star or higher), accessed September 9, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.